Gulf study reveals Real-World use of palbociclib for advanced breast cancer
NCT ID NCT04916509
First seen Jun 07, 2026 · Last updated Jun 16, 2026 · Updated 1 time
Summary
This study reviewed medical records of 258 adults in Gulf countries (like Saudi Arabia and UAE) who took palbociclib for advanced HR+/HER2- breast cancer. Researchers collected information on patient characteristics, treatment patterns, and outcomes like how long the cancer stayed under control. The goal was to understand real-world use, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dubai Hospital
Dubai, United Arab Emirates
-
Hamad Medical Corporation
Doha, Qatar
-
King Abdulaziz Medical City National Guard Hospital
Jeddah, 22384, Saudi Arabia
-
King Abdulaziz Medical City National Guard Hospital Riyahd
Riyadh, 11426, Saudi Arabia
-
King Saud University Medical City Riyadh PO BOX 7805
Riyadh, 11472, Saudi Arabia
-
Mediclinic City Hospital
Dubai, United Arab Emirates
-
Tawam
Al Ain City, United Arab Emirates
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.